Company / PP&E per Share
Tarsus Pharmaceuticals, Inc. PP&E per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.30
FY2025
5-year range
$0.04 / $0.30
FY2021-FY2025
Trend
+349.7%
vs FY2024
Sector context
#68 of 191
Health Care
What the data says
PP&E per Share changed +350% YoY in FY2025, a notable deviation from the 6-year average annual change of +66%.
Based on SEC 10-K filings.
0.30 in FY2025 with a 5-year CAGR of +28.1%.
Improved from $0.05 to $0.30 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +87.4%
- 5-Year CAGR
- +28.1%
- 10-Year CAGR
- -
Sector benchmark
#68 of 191 in Health CareTop 36% of 191This company $0.30 Sector average $22.34
▼
-98.6% below sector average
Key checks
Key Insights
- Tarsus Pharmaceuticals, Inc.'s pp&e per share has grown for 4 consecutive years.
- In FY2025, pp&e per share increased 349.7% year-over-year.
- Ranks #68 out of 191 companies in the Health Care sector.
- Lowest pp&e per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.30 | +349.7% |
| FY2024 | $0.07 | +23.0% |
| FY2023 | $0.05 | +18.9% |
| FY2022 | $0.05 | +24.5% |
| FY2021 | $0.04 | -57.9% |
| FY2020 | $0.09 | +35.4% |
| FY2019 | $0.07 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026